Photochemotherapy for localized morphoea: effect on clinical and molecular markers

N Usmani1, A Murphy, D Veale

  • 1Department of Dermatology, Leeds General Infirmary, Leeds, UK. nailausmani@hotmail.com

Summary

Psoralen ultraviolet A (PUVA) phototherapy shows promise for treating morphoea, with most patients experiencing significant skin score improvement. This treatment also impacts key immune markers, suggesting a potential mechanism of action for morphoea management.

Related Concept Videos